Managing Advanced CLL: A Case-Based Workup and Treatment Review
Dr. Othman Al-Sawaf presented a case study on Chronic Lymphocytic Leukemia, discussing the diagnostic workup, staging, and treatment options for a 65-year-old patient with advanced disease and low-risk CLL.
Target Audience
Healthcare Professionals
This activity is supported by an educational grant from Eli Lilly.
Course summary

Dr. Othman Al-Sawaf
Haematologist and Medical Oncologist, University Hospital Cologne, Cologne, Germany
Principal Investigator, German CLL Study Group (GCLLSG)
Dr. Othman Al-Sawaf discloses the following: Speaker/presentation fees from Roche, Janssen, Gilead, AbbVie, Lilly, AstraZeneca, Adaptive, and BeiGene; research grants from BeiGene, Roche, Janssen, and AbbVie; and consulting fees from Roche, Janssen, Gilead, AbbVie, Lilly, AstraZeneca, Ascentage, BeiGene, and Genmab.
There is no accreditation available for this activity.

Facebook
X
LinkedIn
Forward